Skip to content
Shuttingdown

Anebulo Pharmaceuticals, Inc.

Pharmaceutical Preparations · LAKEWAY · TX

Distress signal

Moderate confidence (50%)

Updated Oct 20, 2026, 12:04 AM

What is happening

Derived by rule set status-rules-2026.09.7

An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

Latest material event: Anebulo Pharmaceuticals, Inc. deregistered its securities (Mar 2, 2026)

Timeline

Every material event, newest first. History is never overwritten.

  1. Anebulo Pharmaceuticals, Inc. deregistered its securities

    Mar 2, 2026

    Registration withdrawn

    • SEC EDGAR — “15-12G 1 form15-12g.htm 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-40388 ANEBULO PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Anebulo Pharmaceuticals, Inc. 1017 Ranch Road 620 South, Suite 107 Lakeway, TX 78734 (512) 598-0931 (Address, including zip code, and telephone number…”

  2. Anebulo Pharmaceuticals, Inc. was delisted from its exchange

    Feb 17, 2026

    Delisting effective

    • SEC EDGAR — “25 1 form25.htm 25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-40388 ANEBULO PHARMACEUTICALS, INC. Exchange: The Nasdaq Stock Market LLC (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered) Anebulo Pharmaceuticals, Inc. 1017 Ranch Road 620 South, Suite 107 Lakeway, TX 78734 (512) 598-0931 (Address, including zip code, and telephone number, including area…”

  3. Anebulo Pharmaceuticals, Inc. received a delisting notice from its exchange

    Feb 5, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On February 5, 2026, the Board of Directors (the Board ) of Anebulo Pharmaceuticals, Inc., a Delaware corporation ( Anebulo or the Company ) approved the voluntary delisting of the Company s common stock, par value $0.001 per share ( Common Stock ), from The Nasdaq Capital Market ( Nasdaq ) and the subsequent voluntary deregistration of the Common Stock with the Securities and Exchange Commission (the SEC ) in order to terminate and suspend its reporting obligations under the Securiti…”

Company information

Founded
—
Employees (estimate)
—
Industry
Pharmaceutical Preparations
Subindustry
—
Listing
SEC lists the ticker ANEB on OTC.
SEC CIK
0001815974
Website
—
LinkedIn
—
Headquarters
LAKEWAY, TX
Also known as
—
Legal entities
Anebulo Pharmaceuticals, Inc.

Sources

Every material source used to build this profile.

  • SEC Company Submissions (TIER 1 · UNVERIFIED)

    Anebulo Pharmaceuticals, Inc. — Pharmaceutical Preparations (SIC 2834) — LAKEWAY, TX
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    15-12G 1 form15-12g.htm 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-40388 ANEBULO PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Anebulo Pharmaceuticals, Inc. 1017 Ranch Road 620 South, Suite 107 Lakeway, TX 78734 (512) 598-0931 (Address, including zip code, and telephone number…
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    25 1 form25.htm 25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-40388 ANEBULO PHARMACEUTICALS, INC. Exchange: The Nasdaq Stock Market LLC (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered) Anebulo Pharmaceuticals, Inc. 1017 Ranch Road 620 South, Suite 107 Lakeway, TX 78734 (512) 598-0931 (Address, including zip code, and telephone number, including area…
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On February 5, 2026, the Board of Directors (the Board ) of Anebulo Pharmaceuticals, Inc., a Delaware corporation ( Anebulo or the Company ) approved the voluntary delisting of the Company s common stock, par value $0.001 per share ( Common Stock ), from The Nasdaq Capital Market ( Nasdaq ) and the subsequent voluntary deregistration of the Common Stock with the Securities and Exchange Commission (the SEC ) in order to terminate and suspend its reporting obligations under the Securiti…
    View source record

Status history

Every derived status, with the rule that produced it.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:32 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:15 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:33 PM

    The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:45 PM

    The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:09 AM

    The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.

  • UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:04 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.